Skip to main content
Top
Published in: Clinical Research in Cardiology 2/2009

01-02-2009 | ORIGINAL PAPER

Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure

Authors: Tom D. J. Smilde, MD, PhD, Kevin Damman, MD, Pim van der Harst, MD, PhD, Gerjan Navis, MD, PhD, B. Daan Westenbrink, MD, Adriaan A. Voors, MD, PhD, Frans Boomsma, PhD, Dirk J. van Veldhuisen, MD, PhD, Dr. Hans L. Hillege, MD, MSc, PhD

Published in: Clinical Research in Cardiology | Issue 2/2009

Login to get access

Abstract

Background

Reduced glomerular filtration rate (GFR) is strongly associated with reduced survival in patients with chronic heart failure (CHF). Our aim was to determine different pathophysiologic markers that are associated with reduced renal function in CHF.

Methods and results

We studied 86 patients with CHF (58 ± 12 years, 78% male). GFR and renal blood flow (RBF) were determined by 125I-Iothalamate and 131I-Hippuran clearances. Filtration fraction (FF) was calculated. We determined haemoglobin levels, endothelial function, inflammatory status, plasma renin activity (PRA) and N-terminal pro brain natriuretic peptide (NT-proBNP). Urinay albumin excretion (UAE) was measured in 24 h urine. Mean GFR was 74 ± 28 ml/min/1.73 m2. GFR was strongly related to RBF (= 0.915, < 0.001), FF (= 0.546, < 0.001), but only weakly to endothelial function and PRA. In multivariate analysis, RBF (r = 0.938, P < 0.001), FF (r = 0.786, < 0.001) and haemoglobin levels (r = −0.520, P < 0.001) were independently associated with GFR. UAE was mainly dependent on RBF (= −0.401, P < 0.001) and increased exponentially with decreasing RBF. RBF was mainly associated with NT-proBNP (= −0.561, < 0.001) and PRA (= −0.422, < 0.001).

Conclusion

Reduced GFR is mainly dependent of decreased RBF in patients with CHF. Endothelial function and neurohormonal activation showed only mild associations with GFR. NT-proBNP showed a strong relationship with RBF, and may be used as a marker of reduced renal perfusion.
Literature
1.
go back to reference Bohm M, Werner N, Kindermann M (2006) Drug treatment of chronic heart failure. Clin Res Cardiol 95(Suppl 4):36–54PubMedCrossRef Bohm M, Werner N, Kindermann M (2006) Drug treatment of chronic heart failure. Clin Res Cardiol 95(Suppl 4):36–54PubMedCrossRef
2.
go back to reference Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 26:11–17PubMedCrossRef Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 26:11–17PubMedCrossRef
3.
go back to reference Bonomini M, Reale M, Santarelli P, Stuard S, Settefrati N, Albertazzi A (1998) Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 79:399–407PubMedCrossRef Bonomini M, Reale M, Santarelli P, Stuard S, Settefrati N, Albertazzi A (1998) Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 79:399–407PubMedCrossRef
4.
go back to reference Brezis M, Rosen S (1995) Hypoxia of the renal medulla–its implications for disease. N Engl J Med 332:647–655PubMedCrossRef Brezis M, Rosen S (1995) Hypoxia of the renal medulla–its implications for disease. N Engl J Med 332:647–655PubMedCrossRef
6.
go back to reference Chong AY, Freestone B, Patel J, Lim HS, Hughes E, Blann AD, Lip GY (2006) Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. Am J Cardiol 97:671–675PubMedCrossRef Chong AY, Freestone B, Patel J, Lim HS, Hughes E, Blann AD, Lip GY (2006) Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. Am J Cardiol 97:671–675PubMedCrossRef
7.
go back to reference Cody RJ, Ljungman S, Covit AB, Kubo SH, Sealey JE, Pondolfino K, Clark M, James G, Laragh JH (1988) Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int 34:361–367PubMedCrossRef Cody RJ, Ljungman S, Covit AB, Kubo SH, Sealey JE, Pondolfino K, Clark M, James G, Laragh JH (1988) Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int 34:361–367PubMedCrossRef
8.
go back to reference Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL (2008) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol accepted for publication Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL (2008) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol accepted for publication
9.
go back to reference Damman K, Navis G, Smilde TD, Voors AA, van der BW, van Veldhuisen DJ, Hillege HL (2007) Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9:872–878PubMedCrossRef Damman K, Navis G, Smilde TD, Voors AA, van der BW, van Veldhuisen DJ, Hillege HL (2007) Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9:872–878PubMedCrossRef
10.
go back to reference Dittrich HC, Gupta DK, Hack TC, Dowling T, Callahan J, Thomson S (2007) The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Card Fail 13:609–617PubMedCrossRef Dittrich HC, Gupta DK, Hack TC, Dowling T, Callahan J, Thomson S (2007) The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Card Fail 13:609–617PubMedCrossRef
11.
go back to reference Donker AJM, Vanderhem GK, Sluiter WJ, Beekhuis H (1977) Radioisotope method for simultaneous determination of glomerular-filtration rate and effective renal plasma-flow. Neth J Med 20:97–103PubMed Donker AJM, Vanderhem GK, Sluiter WJ, Beekhuis H (1977) Radioisotope method for simultaneous determination of glomerular-filtration rate and effective renal plasma-flow. Neth J Med 20:97–103PubMed
12.
go back to reference Evans RG, Eppel GA, Anderson WP, Denton KM (2004) Mechanisms underlying the differential control of blood flow in the renal medulla and cortex. J Hypertens 22:1439–1451PubMedCrossRef Evans RG, Eppel GA, Anderson WP, Denton KM (2004) Mechanisms underlying the differential control of blood flow in the renal medulla and cortex. J Hypertens 22:1439–1451PubMedCrossRef
13.
go back to reference Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC (2007) The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 50:1551–1560PubMedCrossRef Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC (2007) The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 50:1551–1560PubMedCrossRef
14.
go back to reference Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de ZD, Charlesworth A, Hampton JR, van Veldhuisen DJ (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102:203–210PubMed Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de ZD, Charlesworth A, Hampton JR, van Veldhuisen DJ (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102:203–210PubMed
15.
go back to reference Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de ZD, Pocock S, van Veldhuisen DJ (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113:671–678PubMedCrossRef Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de ZD, Pocock S, van Veldhuisen DJ (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113:671–678PubMedCrossRef
16.
go back to reference Hillege HL, van Gilst WH, van Veldhuisen DJ, Navis G, Grobbee DE, de Graeff PA, de Zeeuw D (2003) Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J 24:412–420PubMedCrossRef Hillege HL, van Gilst WH, van Veldhuisen DJ, Navis G, Grobbee DE, de Graeff PA, de Zeeuw D (2003) Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J 24:412–420PubMedCrossRef
17.
go back to reference Ingelsson E, Sundstrom J, Lind L, Riserus U, Larsson A, Basu S, Arnlov J (2007) Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men. Eur Heart J 28:1739–1745PubMedCrossRef Ingelsson E, Sundstrom J, Lind L, Riserus U, Larsson A, Basu S, Arnlov J (2007) Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men. Eur Heart J 28:1739–1745PubMedCrossRef
18.
go back to reference Jensen KT, Carstens J, Pedersen EB (1998) Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol 274:F63–F72PubMed Jensen KT, Carstens J, Pedersen EB (1998) Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol 274:F63–F72PubMed
19.
go back to reference Kilcoyne MM, Schmidt DH, Cannon PJ (1973) Intrarenal blood flow in congestive heart failure. Circulation 47:786–797PubMed Kilcoyne MM, Schmidt DH, Cannon PJ (1973) Intrarenal blood flow in congestive heart failure. Circulation 47:786–797PubMed
20.
go back to reference La Villa G, Fronzaroli C, Lazzeri C, Porciani C, Bandinelli R, Vena S, Messeri G, Franchi F (1994) Cardiovascular and renal effects of low dose brain natriuretic peptide infusion in man. J Clin Endocrinol Metab 78:1166–1171PubMedCrossRef La Villa G, Fronzaroli C, Lazzeri C, Porciani C, Bandinelli R, Vena S, Messeri G, Franchi F (1994) Cardiovascular and renal effects of low dose brain natriuretic peptide infusion in man. J Clin Endocrinol Metab 78:1166–1171PubMedCrossRef
21.
go back to reference Ljungman S, Laragh JH, Cody RJ (1990) Role of the kidney in congestive heart-failure—relationship of cardiac index to kidney-function. Drugs 39:10–21PubMedCrossRef Ljungman S, Laragh JH, Cody RJ (1990) Role of the kidney in congestive heart-failure—relationship of cardiac index to kidney-function. Drugs 39:10–21PubMedCrossRef
22.
go back to reference Marcus LS, Hart D, Packer M, Yushak M, Medina N, Danziger RS, Heitjan DF, Katz SD (1996) Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure: a double-blind, placebo-controlled, randomized crossover trial. Circulation 94:3184–3189PubMed Marcus LS, Hart D, Packer M, Yushak M, Medina N, Danziger RS, Heitjan DF, Katz SD (1996) Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure: a double-blind, placebo-controlled, randomized crossover trial. Circulation 94:3184–3189PubMed
23.
go back to reference Nushiro N, Ito S, Carretero OA (1990) Renin release from microdissected superficial, midcortical, and juxtamedullary afferent arterioles in rabbits. Kidney Int 38:426–431PubMedCrossRef Nushiro N, Ito S, Carretero OA (1990) Renin release from microdissected superficial, midcortical, and juxtamedullary afferent arterioles in rabbits. Kidney Int 38:426–431PubMedCrossRef
24.
go back to reference Pollock CA, Poronnik P (2007) Albumin transport and processing by the proximal tubule: physiology and pathophysiology. Curr Opin Nephrol Hypertens 16:359–364PubMedCrossRef Pollock CA, Poronnik P (2007) Albumin transport and processing by the proximal tubule: physiology and pathophysiology. Curr Opin Nephrol Hypertens 16:359–364PubMedCrossRef
25.
go back to reference Prevot A, Huet F, Semama DS, Gouyon JB, Guignard JP (2002) Complementary effects of adenosine and angiotensin II in hypoxemia-induced renal dysfunction in the rabbit. Life Sci 71:779–787PubMedCrossRef Prevot A, Huet F, Semama DS, Gouyon JB, Guignard JP (2002) Complementary effects of adenosine and angiotensin II in hypoxemia-induced renal dysfunction in the rabbit. Life Sci 71:779–787PubMedCrossRef
26.
go back to reference Ruilope LM, van Veldhuisen DJ, Ritz E, Luscher TF (2001) Renal function: the cinderella of cardiovascular risk profile. J Am Coll Cardiol 38:1782–1787PubMedCrossRef Ruilope LM, van Veldhuisen DJ, Ritz E, Luscher TF (2001) Renal function: the cinderella of cardiovascular risk profile. J Am Coll Cardiol 38:1782–1787PubMedCrossRef
27.
go back to reference Smilde TDJ, Hillege HL, Voors AA, Dunselman PHJ, van Veldhuisen DJ (2004) Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction. Am J Cardiol 94:240–243PubMedCrossRef Smilde TDJ, Hillege HL, Voors AA, Dunselman PHJ, van Veldhuisen DJ (2004) Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction. Am J Cardiol 94:240–243PubMedCrossRef
28.
go back to reference Stam F, van GC, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD (2006) Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol 17:537–545PubMedCrossRef Stam F, van GC, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD (2006) Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol 17:537–545PubMedCrossRef
29.
go back to reference Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27:1201–1206PubMedCrossRef Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27:1201–1206PubMedCrossRef
30.
go back to reference van de Wal RM, Asselbergs FW, Plokker HW, Smilde TD, Lok D, van Veldhuisen DJ, van Gilst WH, Voors AA (2005) High prevalence of microalbuminuria in chronic heart failure patients. J Card Fail 11:602–606PubMedCrossRef van de Wal RM, Asselbergs FW, Plokker HW, Smilde TD, Lok D, van Veldhuisen DJ, van Gilst WH, Voors AA (2005) High prevalence of microalbuminuria in chronic heart failure patients. J Card Fail 11:602–606PubMedCrossRef
31.
go back to reference van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA (2006) Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. Int J Cardiol 106:367–372PubMedCrossRef van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA (2006) Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. Int J Cardiol 106:367–372PubMedCrossRef
32.
go back to reference van der Harst P, Smilde TD, Buikema H, Voors AA, Navis G, van Veldhuisen DJ, van Gilst WH (2006) Vascular function and mild renal impairment in stable coronary artery disease. Arterioscler Thromb Vasc Biol 26:379–384PubMedCrossRef van der Harst P, Smilde TD, Buikema H, Voors AA, Navis G, van Veldhuisen DJ, van Gilst WH (2006) Vascular function and mild renal impairment in stable coronary artery disease. Arterioscler Thromb Vasc Biol 26:379–384PubMedCrossRef
33.
go back to reference van der Horst I, Voors AA, van Veldhuisen DJ (2007) Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists? Clin Res Cardiol 96:193–195PubMedCrossRef van der Horst I, Voors AA, van Veldhuisen DJ (2007) Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists? Clin Res Cardiol 96:193–195PubMedCrossRef
34.
go back to reference van der Zander K, Houben AJ, Hofstra L, Kroon AA, de Leeuw PW (2003) Hemodynamic and renal effects of low-dose brain natriuretic peptide infusion in humans: a randomized, placebo-controlled crossover study. Am J Physiol Heart Circ Physiol 285:H1206–H1212PubMed van der Zander K, Houben AJ, Hofstra L, Kroon AA, de Leeuw PW (2003) Hemodynamic and renal effects of low-dose brain natriuretic peptide infusion in humans: a randomized, placebo-controlled crossover study. Am J Physiol Heart Circ Physiol 285:H1206–H1212PubMed
35.
go back to reference Wannamethee SG, Shaper AG, Lowe GD, Lennon L, Rumley A, Whincup PH (2006) Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers. Eur Heart J 27:2975–2981PubMedCrossRef Wannamethee SG, Shaper AG, Lowe GD, Lennon L, Rumley A, Whincup PH (2006) Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers. Eur Heart J 27:2975–2981PubMedCrossRef
Metadata
Title
Differential associations between renal function and “modifiable” risk factors in patients with chronic heart failure
Authors
Tom D. J. Smilde, MD, PhD
Kevin Damman, MD
Pim van der Harst, MD, PhD
Gerjan Navis, MD, PhD
B. Daan Westenbrink, MD
Adriaan A. Voors, MD, PhD
Frans Boomsma, PhD
Dirk J. van Veldhuisen, MD, PhD
Dr. Hans L. Hillege, MD, MSc, PhD
Publication date
01-02-2009
Publisher
Steinkopff-Verlag
Published in
Clinical Research in Cardiology / Issue 2/2009
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-008-0732-z

Other articles of this Issue 2/2009

Clinical Research in Cardiology 2/2009 Go to the issue